Vaccine Co-Development and Technology Transfer
Leveraging our technical excellence,
we are conducting various joint development and technology transfer projects with global companies
from material supply to product development, clinical trials, and sales.
we are conducting various joint development and technology transfer projects with global companies
from material supply to product development, clinical trials, and sales.
Joint development
We provide the best solution for faster product development with advanced systems for core competitive R&D
and manufacturing processes and future-oriented investments in joint development.
General Practice
- 2.5 Years
- R&D
- NCS (tox)
- 1 Year
- PhaseⅠ/Ⅱ
- 3 Years
- Construction
- CTM* manufacturing
- 2 Years
- Phase Ⅲ
- 1 Year
- BLA
SK’s cell based influenza vaccine case
- 2.5 Years
- R&D
- NCS(tox)
- 1 Year
- PhaseⅠ/Ⅱ
-
- Construction
- CTM* manufacturing
- 1.5 Years
- Phase Ⅲ
- 0.8 Year
- BLA
6 YEARS
from scratch
to the market
Joint development process
- Full or partial funding
-
Preclinical process development
Small scale
manufacturingBIO R&D CENTER
-
Clinical
Commercial scale
manufacturingL HOUSE
- BLA/WHO PQ
-
Supply
Post marketing
commitment
We are working with various global companies and foundations for global healthcare.